These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Follow-up of four HIV-infected individuals after administration of hepatitis C virus and GBV-C/hepatitis G virus contaminated intravenous immunoglobulin: evidence for HCV but not for GBV-C/HGV transmission. Berger A; Doerr HW; Scharrer I; Weber B J Med Virol; 1997 Sep; 53(1):25-30. PubMed ID: 9298728 [TBL] [Abstract][Full Text] [Related]
7. [Liver function tests, hepatitis A, B, C markers and HIV antibodies in patients with Basedow's ophthalmopathy treated with intravenous immunoglobulins]. Antonelli A; Neri S; Gasperini L; Alberti B; Saracino A; Gambuzza C; Agostini S; Baschieri L Clin Ter; 1992 Sep; 141(9 Pt 2):55-61. PubMed ID: 1468200 [TBL] [Abstract][Full Text] [Related]
8. Safety of intravenous immunoglobulin with regard to hepatitis C virus. Yu MW; Mason BL; Guo ZP; Tankersley DL Clin Ther; 1996; 18 Suppl B():71-2. PubMed ID: 8930443 [No Abstract] [Full Text] [Related]
9. Intravenous immunoglobulin and hepatitis C virus: the British episode. Healey C; Chapel H Clin Ther; 1996; 18 Suppl B():93-5. PubMed ID: 8930446 [No Abstract] [Full Text] [Related]
10. Intravenous immunoglobulin and hepatitis C virus: the Boston episode. Schneider LC; Jonas MM; Baron MJ; Mast EF; Alter MJ; Schonberger LB; Lambert S; Coleman P; Bresee JS Clin Ther; 1996; 18 Suppl B():108-9. PubMed ID: 8930448 [No Abstract] [Full Text] [Related]
14. Hepatitis C after intravenous immunoglobulin. Sewell WA; Mullighan CG; Christie J; Chapel HM Ann Allergy Asthma Immunol; 1997 Nov; 79(5):466-7. PubMed ID: 9396984 [No Abstract] [Full Text] [Related]
15. Prospective evaluation of primary infection due to HCV, HGV or TTV in children with newly diagnosed neoplasia. Tasso L; Castagnola E; Lo Giudice C; Torre F; Micalizzi C; Picciotto A; Giacchino R Haematologica; 2001 Jul; 86(7):761-2. PubMed ID: 11454533 [No Abstract] [Full Text] [Related]
16. Infections with hepatotropic viruses in children treated with allogeneic bone marrow transplantation. Locasciulli A; Nava S; Sparano P; Testa M Bone Marrow Transplant; 1998 Apr; 21 Suppl 2():S75-7. PubMed ID: 9630333 [TBL] [Abstract][Full Text] [Related]
17. Gammagard and reported hepatitis C virus episodes. Gomperts ED Clin Ther; 1996; 18 Suppl B():3-8. PubMed ID: 8930438 [TBL] [Abstract][Full Text] [Related]
18. Epidemiological relevance of hepatitis G in Italian dialysis patients with and without hepatitis C infection. Canavese C; Hollò Z; Thea A; Ghisetti V; Brunetto M; Piccoli G Nephrol Dial Transplant; 1997 Sep; 12(9):2038-9. PubMed ID: 9306381 [No Abstract] [Full Text] [Related]
19. [Post-transfusion hepatitis. A pending issue]. Sánchez-Quijano A; Pineda JA; Lissen E Med Clin (Barc); 1988 Jun; 91(3):117-8. PubMed ID: 3139945 [No Abstract] [Full Text] [Related]
20. Hepatitis G virus in intramuscular and intravenous immunoglobulin products manufactured in Europe. Cristiano K; Pisani G; Wirz M; Gentili G Transfusion; 1999 Apr; 39(4):428. PubMed ID: 10220272 [No Abstract] [Full Text] [Related] [Next] [New Search]